Procurement Trends, Indications, and Outcomes of Heart–Lung Transplantation in the Contemporary Era
HLTx volume has resurged, with DCD HLTx emerging as a viable procurement strategy. Factors associated with 1- and 5-year survival may be used to guide postoperative management following HLTx.
Authors
- Richard C. Daly (ORCID: https://orcid.org/0009-0005-4266-0722)
- Elaine M. Griffeth (ORCID: https://orcid.org/0000-0002-0425-2710)
- Omar M. Sharaf (ORCID: https://orcid.org/0000-0002-8840-2869)
- John A. Treffalls (ORCID: https://orcid.org/0000-0001-7732-6963)
- Philip J. Spencer (ORCID: https://orcid.org/0000-0002-7452-3539)
- Qiudong Chen (ORCID: https://orcid.org/0000-0002-2475-4312)
- Sahar A. Saddoughi
- Zachary Brennan (ORCID: https://orcid.org/0000-0001-5553-004X)
- Mauricio A. Villavicencio (ORCID: https://orcid.org/0000-0003-1080-9471)
- Kelly M. Pennington (ORCID: https://orcid.org/0000-0003-1187-5059)
- Ahmet Bilgili (ORCID: https://orcid.org/0000-0002-5449-2114)
Institutions
- Cedars-Sinai Medical Center (US)
- Mayo Clinic (US)
- University of Florida (US)
- Cedars-Sinai Smidt Heart Institute (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/ctr.15447
- Citations
- 3
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.72